Clinical trial · Observational
The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer
The Clinical Significance of Metabolic Adipo-myokines and Alterations of Body Composition in Patients With End Stage Lung Cancer
NCT06060262CI-TRIAL-00070062unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators conduct this prospective study and wish to elucidate the association of serial change of body composition, serum adipo-myokines and adverse effect of chemotherapy and lung cancer prognosis
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Metastatic | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (13)
- measure
- Number of white blood cell change among before, during and after cancer therapy
- timeFrame
- week 0 , week 4 and week 12 after cancer theraphy
- description
- assessing the change of white blood cell count among week 0, week 4 and week 12
- measure
- Percentage of body fat change among before, during and after cancer therapy
- timeFrame
- week 0 , week 4 and week 12 after cancer theraphy
- description
- assessing the change of percentage of body fat among week 0, week 4 and week 12
- measure
- Percentage of total body water change among before, during and after cancer therapy
- timeFrame
- week 0 , week 4 and week 12 after cancer theraphy
- description
- assessing the change of total body water percentage among week 0, week 4 and week 12
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: 1. Diagnosis of lung cancer stage III to stage IV 2. Adults over 20 years old 3. Daily performance status of 0- 2 Exclusion Criteria: 1\. Cardiac stents or pacemakers
References
Publications (0)
Data not yet available
No reference posted for this study.